Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-25 @ 5:05 AM
NCT ID:
NCT03634527
Eligibility Criteria:
Inclusion Criteria:
* Cancer patients who are 18 years of age or olde
* Able to read and write English
* Have CIPN due to received neurotoxic chemotherapy for cancer
* Had average intensity of pain due to CIPN ≥ 4 on a 11-point numerical pain scale in the previous week
* Pain \> 3 months duration attributed to CIPN.
Exclusion Criteria:
* Use of an investigational agent for pain control concurrently or within the past 30 days;
* Use of an implantable drug delivery systems, e.g. Medtronic Synchromed
* Prior celiac plexus block, or other neurolytic pain control treatment
* Other identified causes of painful paresthesia existing prior to chemotherapy (e.g., radiation or malignant plexopathy, lumbar or cervical radiculopathy, pre-existing peripheral neuropathy of another etiology
* Allergy to latex (the tapes for the APA include latex).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03634527
Study Brief:
Protocol Section:
NCT03634527